NIH
►Promising Interim Results from Clinical Trial of NIH-Moderna COVID-19 Vaccine
►Updated: New COVID-19 Treatment Guidelines
►Can Autoimmune Antibodies Explain Blood Clots in COVID-19?
►Hydroxychloroquine Does Not Benefit Adults Hospitalized with COVID-19
►Promising Interim Results from Clinical Trial of NIH-Moderna COVID-19 Vaccine
►Agency Scientists Discover Key Pathway in Lysosomes That Coronaviruses Use to Exit Cells
►Protein Mapping Study Reveals Valuable Clues for COVID-19 Drug Development (Blog)
►Study Highlights Need for Continued Care of COVID-19 Survivors
►Agency Scientists Discover Key Pathway in Lysosomes That Coronaviruses Use to Exit Cells
►Clinical Trials: 631 Listed Studies
►Large Clinical Trial to Test Immune Modulators for Treatment of COVID-19
►Clinical Trial Testing Hyperimmune Intravenous Immunoglobulin Plus Remdesivir to Treat COVID-19 Begins
►RADx Initiative Advances 6 New COVID-19 Testing Technologies
►Scientists Discover Genetic and Immunologic Underpinnings of Some Cases of Severe COVID-19
►Investigational COVID-19 Vaccine Well-tolerated, Generates Immune Response in Older Adults
►Agency to Assess/Expand COVID-19 Testing for Underserved Communities
►Fourth Large-scale COVID-19 Vaccine Trial Begins in U.S.
►Government COVID-19 Resources for Older Adults
►Agency Expands Clinical Trials to Test Convalescent Plasma Against
COVID-19
►ACTIV Initiative Launches Adaptive Clinical Trials of Blood-clotting Treatments for COVID-19
►Agency Funds Community Engagement Research Efforts in Areas Hardest Hit by
COVID-19
►Agency Continues to Boost National COVID-19 Testing Capacity
►Agency-supported Study Tracks Prevalence/Impact of SARS-CoV-2 Among Pregnant Women in . . .
►Phase 3 Clinical Testing in US of AstraZeneca COVID-19 Vaccine Candidate Begins
►Mapping Tool Highlights
►NIH-funded Small Business Successes
►Clinical Trials of Monoclonal Antibodies to Prevent COVID-19 Now Enrolling
►Clinical Trial Testing Remdesivir Plus Interferon Beta-1a For COVID-19 Treatment Begins
►Agency-funded Project Seeks to Identify Children at Risk for MIS-C
►Clinical Trials of Monoclonal Antibodies to Prevent COVID-19 Now Enrolling
►Clinical Trial to Test Antibody Treatment in Hospitalized COVID-19 Patients Launched
►NIH-Moderna Investigational COVID-19 Vaccine Shows Promise in Mouse Studies
►Agency Harnesses AI for COVID-19 Diagnosis, Treatment, and Monitoring
►Clinical Trial to Test Antibodies and Other Experimental Therapeutics for Mild/Moderate COVID-19
►Agency Delivering New COVID-19 Testing Technologies to Meet U.S. Demand
►Experimental COVID-19 Vaccine Protects Upper and Lower Airways in Nonhuman Primates
►Phase 3 Clinical Trial of Investigational Vaccine for COVID-19 Begins
►Agency Leadership Details Unprecedented Initiative to Ramp Up Testing Technologies for COVID-19
►Agency-Wide Strategic Plan for COVID-19 Research
►Experimental COVID-19 Vaccine Safe, Generates Immune Response
►Placenta Lacks Major Molecules Used by SARS-CoV-2 Virus to Cause Infection
►Agency-wide Strategic Plan for COVID-19 Research
►Clinical Trials Network to Test COVID-19 Vaccines and Other Prevention Tools Launched
►ACTIV vaccine working group weighs role of human challenge studies for SARS-CoV-2 vaccine development
►COVID-19 Treatment Guidelines Panel Provides Recommendations for Dexamethasone in Patients with COVID-19
►Updated: Special Considerations in Children
►Investigators Hope CD47 Study Leads to Broad-spectrum Infectious Diseases Immunotherapy
►Experts ID Steps to Expand/Improve Antibody Tests in COVID-19 Response
►Clinical Trials of Hydroxychloroquine Halted
►All of Us Research Pgm Launches COVID-19 research initiatives
►Analytics Platform to Harness Nationwide COVID-19 Patient Data to Speed Treatments Launched
►Researchers ID Key Genomic Features: Could Differentiate SARS-CoV-2 From Other Coronaviruses That Cause Less Severe Disease
►Study identifies potential approach to treat severe respiratory distress in COVID-19 patients
►NIH-funded study evaluates drugs prescribed to children w/COVID-19
►What’s New in Treatment Guidelines
►COVID-19: Treatment Guidelines
►Initiative mobilizes national innovation for COVID-19 diagnostics
►ACTIV Research Initiative: ACCELERATING COVID-19 THERAPEUTIC INTERVENTIONS AND VACCINES
►COVID-19 Treatment Guidelines